Elanco Animal Health Inc 4

EVP and CFO Robert M. VanHimbergen received a small compensation-related award of 7.9093 deferred stock units tied to Elanco Animal Health Inc. common stock.

On July 24, 2026, Elanco Animal Health Inc. EVP and CFO Robert M. VanHimbergen received a routine award of deferred stock units under the company’s Executive Deferral and Stock Match Plan, representing 7.9093 deferred stock units that correspond to an equivalent number of shares of common stock and will settle in cash or stock following termination of employment or in a specified future year. The filing shows no open-market purchase or sale, but rather a compensation-related accrual, with an associated notation that after the transaction he beneficially owns 124.6979 shares (or equivalent units) on a direct basis. Using the plan’s stated value of approximately $24.91 per share, the grant is worth roughly $197, while his total reported direct ownership value is about $3,105, both of which are financially immaterial and characteristic of standard executive deferral activity rather than a signal-driven trade.

Filing Facts

CIK

1739104

Ticker

ELAN

Form

4

Source Type

fda

Accession

0001724169-26-000035

Alert Tier

4